Virus-induced diabetes in a transgenic model: Role of cross-reacting viruses and quantitation of effector T cells needed to cause disease

Journal of Virology

Volumn 74, Issue 7, 2000, Pages 3284-3292

  Sevilla, Noemi ^a   Homann, Dirk ^a   Von Herrath, Matthias ^a   Rodriguez, Fernando ^a   Harkins, Stephanie ^a   Whitton, J Lindsay ^a   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; CELL COUNT; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; DIABETES MELLITUS; DIABETOGENESIS; EFFECTOR CELL; INSULIN DEPENDENT DIABETES MELLITUS; MODEL; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS; VIRUS PATHOGENESIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; CROSS REACTIONS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; DNA PRIMERS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES; VERO CELLS;

EID: 0034011436     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.7.3284-3292.2000     Document Type: Article

References (42)

1. Ahmed, R., A. Salmi, L. D. Butler, J. M. Chiller, and M. B. A. Oldstone. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice: role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160:521-540.
2. Baekkeskov, S., and B. Hansen (ed.). 1990. Human diabetes: Genetic, environmental and autoimmune etiology, vol. 164. Springer-Verlag, Heidelberg, Germany.
3. Borrow, P., C. F. Evans, and M. B. A. Oldstone. 1995. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J. Virol. 69:1059-1070.
4. Buchmeier, M. J., H. A. Lewicki, O. Tomori, and M. B. A. Oldstone. 1981 Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses. Virology 113:73-85.
5. Coon, B., L. L. An, J. L. Whitton, and M. G. von Herrath. 1999. DNA immunization to prevent autoimmune diabetes. J. Clin. Investig. 104:189-194.
6. Dutko, F. J., and M. B. A. Oldstone. 1983. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64:1689-1698.
7. Eisenlohr, L. C., J. W. Yewdell, and J. R. Bennink. 1992. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175:481-487.
8. Fajans, S. S. 1994. Diabetes mellitus: definition, classification, tests, p. 1411. In L. DeGroot (ed.), Endocrinology. Grune and Stratton, New York, N.Y.
9. Forrest, J., M. A. Menser, and J. Burgess. 1991. High frequency of diabetes mellitus in young adults with congenital rubella. Lancet i:332-334.
10. Gamble, D. R., K. W. Taylor, and H. Cumming. 1973. Coxsackie viruses and diabetes mellitus. Br. Med. J. 4:260-262.
11. Horwitz, M. S., L. M. Bradley, J. Harbertson, T. Krahl, J. Lee, and N. Sarvetnick. 1998. Diabetes induced by coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 4:781-785.
12. Jenson, A. B., H. S. Rosenberg, and A. L. Notkins. 1980. Pancreatic islet cell damage in children with fatal viral infections. Lancet ii:354-358.
13. Lee, M.-S., M. von Herrath, H. Reiser, M. B. A. Oldstone, and N. Sarvetnick. 1995. Sensitization to self (virus) antigen by in situ expression of murine interferon-γ. J. Clin. Investig. 95:486-492.
14. Lewicki, H., A. Tishon, P. Borrow, C. Evans, J. E. Gairin, K. M. Hahn, D. A. Jewell, I. A. Wilson, and M. B. A. Oldstone. 1995. CTL escape viral variants. I. Generation and molecular characterization. Virology 210:29-40.
15. Lewicki, H. A., M. G. von Herrath, C. F. Evans, J. L. Whitton, and M. B. A. Oldstone. 1995. CTL escape viral variants. II. Biological activity in vivo. Virology 211:443-450.
16. Moudgil, K. D., I. S. Grewal, P. E. Jensen, and E. E. Sercarz. 1996. Unresponsiveness to a self-peptide of mouse lysozyme owing to hindrance of T cell receptor-major histocompatibility complex/peptide interaction caused by flanking epitopic residues. J. Exp. Med. 183:535-546.
17. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-187.
18. National Diabetes Data Group. 1995. Diabetes in America, 2nd ed. Publication no. 95-1468. National Institutes of Health, Bethesda, Md.
19. Notkins, A. L., T. Onodera, and B. Prabhakar. 1984. Virus induced autoimmunity, p. 210-215. In A. L. Notkins and M. B. A. Oldstone (ed.), Concepts in viral pathogenesis. Springer-Verlag, Heidelberg, Germany.
20. Ohashi, P., S. Oehen, K. Buerki, et al. 1991. Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305-317.
21. Oldstone, M. B. A., R. Ahmed, and M. Salvato. 1990. Viruses as therapeutic agents. II. Viral reassortants map prevention of insulin-dependent diabetes mellitus to the small RNA of lymphocytic choriomeningitis virus. J. Exp. Med. 171:2091-2100.
22. Oldstone, M. B. A., N. Nerenberg, P. Southern, J. Price, and H. Lewicki. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65:319-331.
23. Oldstone, M. B. A., P. Southern, M. Rodriguez, and P. Lampert. 1984. Virus persists in beta cells of islets of Langerhans and is associated with chemical manifestations of diabetes. Science 224:1440-1443.
24. Oldstone, M. B. A., M. von Herrath, H. Lewicki, D. Hudrisier, J. L. Whitton, and J. E. Gairin. 1999. Use of a high-affinity peptide that aborts MHC restricted cytotoxic T lymphocyte activity against multiple viruses in vitro and virus-induced immunopathologic disease in vivo. Virology 256:246-257.
25. Olmos, P., R. A'Hern, D. A. Heaton, et al. 1988. The significance of concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 31:747-750.
26. Ossendorp, F., M. Eggers, A. Neisig, T. Ruppert, M. Groettrup, A. Sijts, E. Mengede, P.-M. Kloetzel, J. Neefjes, U. Koszinowski, and C. Melief. 1996. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 5:115-124.
27. Richter, W., K. M. Jury, D. Loeffler, B. J. Manfras, T. H. Eiermann, and B. O. Boehm. 1995. Immunoglobulin variable gene analysis of human autoantibodies reveals antigen-driven immune response to glutamate decarboxylase in type 1 diabetes mellitus. Eur. J. Immunol. 25:1703-1712.
28. Rodriguez, F., L. L. An, S. Harkins, J. Zhang, M. Yokoyama, G. Widera, J. T. Fuller, C. Kincaid, I. L. Campbell, and J. L. Whitton. 1998. DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. J. Virol. 72:5174-5181.
29. Salvato, M., E. Shimomaye, P. Southern, and M. B. A. Oldstone. 1988. Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) and that of its variant, Clone 13 (CTL-). Virology 164:517-522.
30. Smithells, R., S. Sheppard, W. Marshall, and C. Peckham. 1978. Congenital rubella and diabetes mellitus. Lancet i:439.
31. Tian, J., P. V. Lehmann, and D. L. Kaufman. 1994. T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J. Exp. Med. 180:1979-1984.
32. von Herrath, M., J. Dockter, and M. B. A. Oldstone. 1994. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1:231-242.
33. von Herrath, M. G., B. Coon, H. Lewicki, H. Mazarguil, J. E. Gairin, and M. B. A. Oldstone. 1998. In vivo treatment with a MHC class I restricted blocking peptide can prevent virus-induced autoimmune diabetes. J. Immunol. 161:5087-5096.
34. von Herrath, M. G., J. Dockter, M. Nerenberg, J. E. Gairin, and M. B. A. Oldstone. 1994. Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus. J. Exp. Med. 180:1901-1910.
35. von Herrath, M. G., S. Efrat, M. B. A. Oldstone, and M. S. Horwitz. 1997. Expression of adenovirus E3 transgenes in β cells prevents autoimmune diabetes. Proc. Natl. Acad. Sci. USA 94:9808-9813.
36. von Herrath, M. G., S. Guerder, H. Lewicki, R. A. Flavell, and M. B. A. Oldstone. 1995. Coexpression of B7.1 and viral ("self") transgenes in pancreatic β cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 3:727-738.
37. von Herrath, M. G., and M. B. A. Oldstone. 1997. Interferon-γ is essential for destruction of β cells and development of insulin-dependent diabetes mellitus. J. Exp. Med. 185:531-539.
38. Whitton, J. L., P. J. Southern, and M. B. A. Oldstone. 1988. Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology 162:321-327.
39. Whitton, J. L., A. Tishon, H. Lewicki, J. Gebhard, T. Cook, M. Salvato, E. Joly, and M. B. A. Oldstone. 1989. Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an inimunodominant region which induces nonreciprocal CTL cross-reactivity. J. Virol. 63:4303-4310.
40. Yamamoto, D. 1994. Possible mechanisms of autoantibody production and the connection of viral infections in human autoimmune diseases. J. Exp. Med. 173:75-82.
41. Yokoyama, M., J. Zhang, and J. L. Whitton. 1995. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69:2684-2688.
42. Yoon, J. W., M. Austin, T. Onodera, and A. L. Notkins. 1979. Virus-induced diabetes mellitus: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N. Engl. J. Med. 300:1173-1179.